Tranilast, an anti-allergic drug, down-regulates the growth of cultured neurofibroma cells derived from neurofibromatosis type 1

Tohoku Journal of Experimental Medicine

Volumn 217, Issue 3, 2009, Pages 193-201

  Yamamoto, Misa ^a   Yamauchi, Toshihiko ^b   Okano, Kozue ^a   Takahashi, Mutsuo ^a   Watabe, Shoji ^a   Yamamoto, Yoshimi ^c  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Co culture; Mast cell; Neurofibroma; Tranilast; Von Recklinghausen disease

Indexed keywords

ANTIALLERGIC AGENT; HISTAMINE; STEM CELL FACTOR; TRANILAST; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRYPTASE; ANTHRANILIC ACID DERIVATIVE;

ARTICLE; BENIGN TUMOR; CANCER INHIBITION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHIC SCAR; KELOID; MAST CELL; MEDIATOR RELEASE; NEUROFIBROMA; NEUROFIBROMATOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; SCHWANN CELL; TUMOR CELL CULTURE; CYTOLOGY; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY;

ANTHRANILIC ACIDS; ANTI-ALLERGIC AGENTS; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; HUMANS; MAST CELLS; NEUROFIBROMATOSIS 1; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRYPTASES;

EID: 66149141020     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.217.193     Document Type: Article

References (28)

1. Broudy, V.C. (1997) Stem cell factor and hematopoiesis. Blood, 90, 1345-1364.
2. Fukushima, H., Ohsawa, M., Ikura, Y., Naruko, T., Sugama, Y., Suekane, T., Kitabayashi, C., Inoue, T., Hino, M. & Ueda, M. (2006) Mast cells in diffuse largo B-cell lymphoma; their role in fibrosis. Histopathology, 49, 498-505.
3. Hallgren, J., Spillmann, D., & Pejler, O. (2001) Structural requirements and mechanism for heparin-induced activation of a recombinant mouse mast cell trypatse, mouse mast cell protease-6: formation of active tryptase monomers in the presence of low molecular weight heparin. J. Biol. Chem., 276, 42774-42781.
4. Harvima, R.J., Harvima, I.T., Dull, D., Dunder, U.K. & Schwartz, L.B. (1999) Identification and characterization of multiple forms of tryptase from human mast cells. Arch Dermatol. Res., 291, 73-80.
5. He, S.H., Chen, H.Q. & Zheng, J. (2004) Inhibition of tryptase and chymase induced nucleated cell infiltration by protemase inhibitors. Acta Pharmacol. Sin., 25, 1677-1684.
6. He, S.H., Xie, H. & Fu, Y.L. (2005) Activation of human tonsil and skin mast cells by agonists of proteinase activated receptor-2. Acta Pharmacol. Sin., 26, 568-574.
7. Hedstrom, G., Berglund, M., Molin, D., Fischer, M., Nilsson, G., Thunberg, U., Book, M., Sundstrom, C., Rosenquist, R., Roos, G., Erlanson, M., Amini, R.M. & Enblad, G. (2007) Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma. Br. J. Haematol., 138, 68-71.
8. Herzenberg, L.A., Sweet, R.G. & Herzenberg, L.A. (1976) Fluorescence-activated cell sorting. Sci. Am., 197, 108-117.
9. Jones, S.E., Gilbert, R.E. & Kelly, D.J. (2004) Tranilast reduces mesentric vascular collagen deposition and chymase-positive mast cells in experimental diabetes. J. Diabetes Complications, 18, 309-315.
10. Krishan, A. (1975) Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell. Biol., 66, 188-193.
11. Linenberger, M.L., Jacobson, F.W., Bennett, L.G., Broudy, V.C., Martin, F.H. & Abkowitz, J.L. (1995) Stem cell factor production by human marrow stromal fibroblasts. Exp. Hematol., 10, 1104-1114.
12. Riccardi, V.M. (1981) Cutaneous manifestation of neurofibromatosis: cellular interaction, pigmentation, and mast cells. Birth Defects Orig. Artic. Ser., 17, 129-145.
13. Rottem, M., Okada, T., Goff, J.P. & Metcalfe, D.D. (1994) Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population. Blood, 84, 2489-2496.
14. Rygol, B., Kyrcz-Krzemien, S., Pajiak, J., Konicki, P., Kowai, E. & Gasinska, T. (2007) Tryptase- and chymase-positive mast cells as possible prognostic factor in patients with Hodgkin's lymphoma. Pol. Arch. Med. Wewn., 117, 27-32.
15. Schwartz, L.B., Bradford, T.R., Littman, B.H. & Wintroub, B.U. (1985) The fibrinogenolytic activity of purified tryptase from human lung mast cells. J. Immunol., 135, 2762-2767.
16. Suzawa, H., Kikuchi, S., Ichikawa, K. & Koda, A. (1992a) Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes-macrophages. Jpn J. Pharmacol., 60, 85-90.
17. Suzawa, H., Kikuchi, S., Arai, N. & Koda, A. (1992b) The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. Jpn J. Pharmacol., 60, 91-96.
18. Ujiie, A., Kojima, M., Naito, J., Nakazawa, M. & Koda, A. (1984) Effect of N-5′ on histamine release from rat peritoneal exudate cells induced by calcium ionophore and ATP. Jpn J. Pharmacol., 34, 9-14.
19. Valent, P., Spanblochl, E., Sperr, W.R., Sillaber, C., Zsebo, K.M., Agis, H., Strobl, H., Geissler, K., Bettelheim, P. & Lechner, K. (1992) Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood, 80, 2237-2245.
20. Viskochil, D., Buchberg, A.M., Xu, G., Cawthon, R.M., Stevens, J., Wolff, R.K., Culver, M., Carey, J.C., Copeland, N.G. & Jenkins, N.A. (1990) Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell, 62, 187-192.
21. Viskochil, D.H. (2003) It takes two to tango: mast cell and Schwann cell interactions in neurofibromas. J. Clin. Invest., 112, 1791-1793.
22. Wallace, M.R., Marchuk, D.A., Andersen, L.B., Letcher, R., Odeh, H.M., Saulino, A.M., Fountain, J.W., Brereton, A., Nicholson, J. & Mitchell, A.L. (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science, 249, 181-186.
23. Ward, M.R., Sasahara, T., Agrotis, A., Dilley, R.J., Jennings, G.L. & Bobik, A. (1998) Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injured arteries. Atherosclerosis., 137, 2267-2275.
24. Yagle, M.K., Parruti, G., Xu, W., Ponder, B.A. & Solomon, E. (1990) Genetic and physical map of the von Recklinghausen neurofibromatosis (NF1) region on chromosome 17. Proc. Natl. Acad. Sci. USA., 87, 7255-7259.
25. Yang, F.C., Ingram, D.A., Chen, S., Hingtgen, C.M., Ratner, N., Monk, K.R., Clegg, T., White, H., Mead, L., Wenning, M.J., Williams, D.A., Kapur, R., Atkinson, S.J. & Clapp, D.W. (2003) Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells. J. Clin. Invest., 112, 1851-1861.
26. Yano, H., Kinuta, M., Tateishi, H., Nakano, Y., Matsui, S., Monden, T., Okamura, J., Sakai, M. & Okamoto, S. (1999) Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis. Gastric Cancer., 1, 26-32.
27. Xu, L.H., Liu, Y. & He, X.H. (2005) Inhibitory effects of berberine on the activation and cell cycle progression of human peripheral lymphocytes. Cell Mol. Immunol., 4, 295-300.
28. Zhu, Y., Ghosh, P., Charnay, P., Burns, D.K. & Parada, L.F. (2002) Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science, 3, 920-922.